AMCG Co., Ltd. operates as a cardiac diagnostic and reading solution service company. The company offers magnetocardiography system, a cardiac diagnostic testing device. It also develops technology and clinical pipeline plans for ischaemia, myocarditis, sudden cardiac death, chronic coronany syndrome, acute coronary syndrome, paroxysmal atrial fibrillation, ventricular remodeling, atrium reconstruction, placenta insufficiency, and foetal heart detect indications. The company was founded in 2021 and is based in Seoul, South Korea.
Metrics to compare | 495900 | Peers Peers - average of corresponding metrics from companies closely matching 495900: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship495900PeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 3.3x | |
Upside (Analyst Target) | 0.0% | 0.0% | 44.8% | |
Fair Value Upside | Unlock | 0.0% | 5.0% | Unlock |